August 3, 2026Open Access
View Full PaperBlinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial
Key Points
- The study aims to evaluate the effects of blinded withdrawal of finerenone in patients with heart failure after prolonged treatment.
- Conducted as a randomized trial
- Included patients from the FINEARTS-HF trial
- Assessed patient outcomes following finerenone withdrawal
- Patients experienced significant adverse effects post-withdrawal compared to continuation (p<0.05)
- Long-term treatment showed benefits that diminished after withdrawal
- Resulting implications for ongoing heart failure management strategies
Expert Takes4 quotes
1/4
“This analysis offers a rare glimpse into what happens when patients stop taking an MRA.”
Harlan Krumholz, Professor of medicine and public health, Yale UniversityYale Universityauto_pipelineView source